116.45 +16.95 (17.04%)
Pre-Market: 8:54AM EDT
|Bid||115.68 x 1300|
|Ask||115.75 x 1400|
|Day's Range||97.12 - 121.76|
|52 Week Range||20.10 - 300.00|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||49.33|
Shares of Tilray surged in early trading Tuesday after the marijuana company announced that it had successfully provided its medical cannabis to critically ill children in Australia.
Medical marijuana company Tilray rose 94 percent before crashing in a single day of trading. But not all was lost. Tilray finished 40 percent higher than where it started and brought in $6.5 million worth of shares.
The cannabis company that has lost about $200 per share from the intraday peak of last week’s wild ride climbed in pre-market trading Tuesday, leading gains among pot peers and setting the stock up to break its longest losing streak since its July IPO. The stock gained as much as 23 percent pre-market after expanding its medical cannabis exports to three hospitals in Australia to treat children suffering from epilepsy. Canopy Growth Corp., which briefly yielded its title as the biggest cannabis company to Tilray last week, won a new bull with a a buy rating and $100 Street-high price target from Benchmark.
NEW YORK, NY / ACCESSWIRE / September 25, 2018 / While one marijuana stock saw big gains on Monday another one came crashing down. Tilray saw big losses again on Monday despite a positive announcement. ...
Enthusiasm for pot stocks reached a fever pitch last week when investors piled into British Columbia-based Tilray Inc., a developer of cannabis medicinal products, doubling its stock price over three trading days through Wednesday. Volume for Tilray’s stock had averaged 7 million shares a day since it went public on July 18. Investors were already plenty high on pot stocks before Tilray came along.
Tilray will distribute its CBD 100 product to three hospitals in the state of Victoria via its wholly-owned subsidiary Tilray Australia New Zealand Pty Ltd. The products are being supplied to Royal Children’s Hospital, Monash Children’s Hospital and Austin Health with support from the Government of Victoria’s Department of Health and Human Services, Victoria (DHHS), where they will be distributed to children suffering from intractable epilepsy.
New Age Beverages shares tumble on heavy volume, as they extend their pullback from record highs, while Tilray’s stock heads for a third straight selloff, as investors continued to adjust their cannabis positions ahead of Canada’s full-legalization next month.
Last week, Tilray's stock posted a 12.8 percent gain after some sharp moves. Tilray's stock surged more than 77 percent in the first three trading days of last week but then dropped 47.9 percent to close out the week. Shares of Canadian pot grower Tilray TLRY fell sharply on Monday, erasing gains from a wild week that captivated investors everywhere.
, the first marijuana IPO in the United States, has been having a heyday in the market, with one of the most astonishing sessions earlier this week that saw the stock shoot up over 90% before closing lower. What is the history of marijuana, and how did we get here? Learn more about strains and different kinds of marijuana.
Since going public at $17 per share at the end of July, shares of Canadian cannabis producer Tilray (NASDAQ:TLRY) had gone so far, so fast that TLRY stock had bubble written all over it. It appears the TLRY stock bubble has finally popped. On Wednesday, September 19, TLRY stock passed the $200 and $300 marks in the same day.
The nondescript headquarters of Canadian pot producer Tilray Inc., whose market value briefly exceeded that of American Airlines Group Inc. last week, is a beige, two-story building with blue trimmings in sleepy Nanaimo, a two-hour ferry ride from Vancouver. “Marijuana’s the flavor of the year -- everybody’s been clamoring to buy,” says Mike Tomkins, an independent financial adviser in Nanaimo, who’s had several clients that invested in Tilray in recent months.
The week ending September 21 was broadly positive for the cannabis sector. The Horizons Marijuana Life Sciences ETF (HMMJ) rose 11.6% from its closing on September 14 to its closing on September 21. The Emerging Marijuana Growers Index ETF (HMJR) rose 1.7%, while the ETFMG Alternative Harvest ETF (MJ) rose 10.4% during the same period.
Tilray Inc., the cannabis company that saw a nearly 200-point swing last week, is off to a poor start this week, falling in pre-market trading and leading other cannabis stocks lower.
TORONTO—Shannon Soqui just quit his Wall Street job to go after what he thinks is a bigger business: selling marijuana the way Mary Kay Inc. sells cosmetics. The 51-year-old banker wants to focus on Qind, his San Francisco startup that organizes home parties to sell cannabis products, to get a piece of what he says could sprout into a $100 billion annual business in the U.S. Entrepreneurs and investors are rushing headlong into the nascent legal marijuana industry, fueling a stock craze reminiscent of the late 1990s dot-com bubble and the recent bitcoin mania.
The Dow Jones and S&P 500 pushed further into new high ground Friday, while tech stocks lagged again. McDonald's was a top performer in the Dow.
How can you tell whether a huge winner will keep going up or fall back to earth? Learn to spot a climax run like the one by Axon Enterprise in 2004.
The Dow Jones industrials hold a weekly gain of 2.2% through afternoon trading. Home Depot, Pfizer and Microsoft show leadership. Tilray plunged.